Stratos Wealth Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-112,800
Closed -$455K 1552
2025
Q2
$455K Buy
112,800
+34,800
+45% +$113K 0.01% 961
2025
Q1
$213K Sell
78,000
-80
-0.1% -$287 ﹤0.01% 1248
2024
Q4
$332K Buy
78,080
+41,720
+115% +$159K ﹤0.01% 1108
2024
Q3
$107K Sell
36,360
-17,720
-33% -$56.4K ﹤0.01% 1389
2024
Q2
$188K Buy
54,080
+23,375
+76% +$78K ﹤0.01% 1276
2024
Q1
$87.5K Buy
+30,705
New +$94.7K ﹤0.01% 1341

Other funds holding SRTA

Stratos Wealth Partners's SRTA Position: Q3 2025 in Review

Stratos Wealth Partners sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 112,800 shares — an estimated $455K sold.

Stratos Wealth Partners first reported a position in SRTA in Q1 2024 and held it in 6 quarters. The position peaked at $455K in Q2 2025. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

  • Stratos Wealth Partners reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
  • Stratos Wealth Partners sold 112,800 Strata Critical Medical Inc shares in Q3 2025, an estimated $455K.
  • Stratos Wealth Partners first reported a position in Strata Critical Medical Inc in Q1 2024 and held it in 6 quarters.
  • Stratos Wealth Partners's Strata Critical Medical Inc position peaked at $455K in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on Stratos Wealth Partners's 13F filing for Q3 2025, filed 6 Nov 2025.